Area public health officials have been tracking clusters of drug-resistant Shigella infections, with 16 reported cases in the Portland metro area since September 2023.
Vaccination, testing and treatment and symptom relief information for healthcare providers, updated summer 2023.
Long-acting benzathine penicillin G (brand name Bicillin® L-A & others) is the cornerstone of syphilis treatment an is in shortage in the United States.
Xylazine has recently been confirmed to have contributed to a Portland area fatal overdose in late 2022, confirming that it is a risk to our community.
Providers can help by creating more same-day appointments for sick children and tell families about how to manage symptoms at home, recognize concerning symptoms, use good hand hygiene, disinfection.
Updated interim guidance for hMPXV, updates previous guidance.
Community transmission has been documented in Oregon. There are more testing options and prior approval from state public health is no longer required.
New alert updates guidance for clinical features, specimen collection, isolation
Globally, several cases so far have identified as men who have sex with men, but the virus is not a sexually transmitted disease per se and can affect anyone.
Since we published this resource in April, many new resources have become available
Outpatient SARS-CoV-2 anti-viral and monoclonal therapies can be life saving for high-risk individuals. They require initiation early in the disease course to be effective.
COVID-19 cases and hospitalizations are expected to continue to accelerate in the next 4 weeks because of the highly contagious omicron variant.